ADVANCES IN THE DIAGNOSIS AND TREATMENT OF THE RHEUMATIC DISEASES
Date: June 4th-5th, 2010
Now in its sixth year, this two-day symposium has been planned for the providers of care to patients with rheumatic diseases. Given the wide variety of rheumatologic disorders, and an ever-increasing number of diagnostic procedures and treatment options, it is necessary to provide clinicians with information about strategies for the early diagnosis of these conditions, novel state-of-the-art diagnostic tools, and opportunities to utilize the most effective treatments to ensure optimal patient outcomes.
Who Should Attend
This activity is intended for rheumatologists, internists, gerontologists, orthopedic surgeons,
nurses, nurse practitioners, and other allied health professionals.
Objectives
After attending this activity, the participant should be able to:
- Discuss recent advances in the use of biologic agents in the treatment of rheumatoid arthritis
- Appreciate new treatment options for patients with psoriatic arthritis
- Discuss new and emerging issues in the management of osteoporosis
- Identify major issues related to the management of patients suffering from chronic pain
- Recognize the major dermatologic manifestations of the rheumatic diseases
- Identify how to diagnose and manage osteoarthritis-related shoulder, foot, and ankle disorders
- Appraise current management approaches and controversies in the diagnosis and treatment of lyme disease
- Discuss new treatment strategies in systemic lupus erythematosus
- Appreciate the role of biologic therapy in the treatment of systemic vasculitis
Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council
for Continuing Medical Education through the joint sponsorship of The Johns Hopkins University School of Medicine and The
Institute for Johns Hopkins Nursing. The Johns Hopkins University School of Medicine is accredited by the ACCME to provide
continuing medical education for physicians.
Credit Designation Statement
The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 14.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Nursing Credit
The Institute for Johns Hopkins Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This 14.3 contact hour Educational Activity is provided by The Institute for Johns Hopkins Nursing.
The Institute for Johns Hopkins Nursing is approved as a provider of nurse practitioner continuing education by the American Academy of Nurse Practitioners: AANP Provider Number 061216.
This program has been granted 14.3 contact hours of continuing education (pharmacology hours are pending).
Other Credit
The Johns Hopkins University has approved this activity for 14.75 contact hours for non-physicians.
Policy on Speaker and Provider Disclosure
It is the policy of The Johns Hopkins University School of Medicine and The Institute for Johns Hopkins Nursing that the
speaker and provider disclose real or apparent confl icts of interest relating to the topics of this educational activity, and
also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). The Johns Hopkins
University School of Medicine OCME has established policies in place that will identify and resolve all confl icts of interest prior
to this educational activity. Detailed disclosure will be made in the activity handout materials.
Acknowledgement
Applications for commercial support from health care related industries are pending. A complete list of contributors will be provided in the syllabus.
